[go: up one dir, main page]

Pugh et al., 2013 - Google Patents

The genetic landscape of high-risk neuroblastoma

Pugh et al., 2013

View HTML
Document ID
577495328255370998
Author
Pugh T
Morozova O
Attiyeh E
Asgharzadeh S
Wei J
Auclair D
Carter S
Cibulskis K
Hanna M
Kiezun A
Kim J
Lawrence M
Lichenstein L
McKenna A
Pedamallu C
Ramos A
Shefler E
Sivachenko A
Sougnez C
Stewart C
Ally A
Birol I
Chiu R
Corbett R
Hirst M
Jackman S
Kamoh B
Khodabakshi A
Krzywinski M
Lo A
Moore R
Mungall K
Qian J
Tam A
Thiessen N
Zhao Y
Cole K
Diamond M
Diskin S
Mosse Y
Wood A
Ji L
Sposto R
Badgett T
London W
Moyer Y
Gastier-Foster J
Smith M
Auvil J
Gerhard D
Hogarty M
Jones S
Lander E
Gabriel S
Getz G
Seeger R
Khan J
Marra M
Meyerson M
Maris J
Publication year
Publication venue
Nature genetics

External Links

Snippet

Neuroblastoma is a malignancy of the developing sympathetic nervous system that often presents with widespread metastatic disease, resulting in survival rates of less than 50%. To determine the spectrum of somatic mutation in high-risk neuroblastoma, we studied 240 …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for mutation or polymorphism detection
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/22—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for sequence comparison involving nucleotides or amino acids, e.g. homology search, motif or SNP [Single-Nucleotide Polymorphism] discovery or sequence alignment
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Similar Documents

Publication Publication Date Title
Pugh et al. The genetic landscape of high-risk neuroblastoma
Garsed et al. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Chang et al. The landscape of driver mutations in cutaneous squamous cell carcinoma
Newman et al. Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing
Ma et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Kanchi et al. Integrated analysis of germline and somatic variants in ovarian cancer
Sun et al. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment
Bai et al. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival
Imielinski et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing
Suzuki et al. Sequencing and phasing cancer mutations in lung cancers using a long-read portable sequencer
Sausen et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
Gao et al. Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells
Li et al. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Terraf et al. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
Litchfield et al. Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Yoshida et al. The landscape of somatic mutations in Down syndrome–related myeloid disorders
Park et al. Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits
Quesada et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
US11149316B2 (en) Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
Mengelbier et al. Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
Zhou et al. Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Guo et al. The discrepancy among single nucleotide variants detected by DNA and RNA high throughput sequencing data
Choo et al. Most large structural variants in cancer genomes can be detected without long reads
Börcsök et al. Detection of molecular signatures of homologous recombination deficiency in bladder cancer
Kim et al. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival